SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'AF3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KB9_A_PCFA514_0 (CYTOCHROME B CYTOCHROME C1, HEME PROTEIN UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN I UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT)	4jvs	PUTATIVE UNCHARACTERIZED PROTEIN RAS-RELATED PROTEIN RAB-1A (Legionella drancourtii; Homo sapiens)	4 / 8	ILE B 76 VAL A 438 MET A 445 SER B 42	None None None AF3 B 401 (-2.0A)	1.10A	1kb9A-4jvsB: undetectable 1kb9C-4jvsB: undetectable 1kb9D-4jvsB: undetectable 1kb9E-4jvsB: undetectable	1kb9A-4jvsB: 18.41 1kb9C-4jvsB: 17.16 1kb9D-4jvsB: 19.92 1kb9E-4jvsB: 20.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RMT_A_ADNA1501_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	10 / 10	ASP A 46 PHE A 56 TYR A 70 LEU A 71 TRP A 77 THR A 112 GLY A 113 ARG A 114 THR A 192 TYR A 193	AF3 A 800 ( 3.7A) None None None None AF3 A 800 (-3.6A) AF3 A 800 (-3.5A) None None None	0.31A	1rmtA-2hf7A: 33.9	1rmtA-2hf7A: 99.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RMT_C_ADNC1503_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	8 / 8	ASP A 46 PHE A 56 TYR A 70 LEU A 71 TRP A 77 GLY A 113 ASP A 145 TYR A 193	AF3 A 800 ( 3.7A) None None None None AF3 A 800 (-3.5A) None None	0.26A	1rmtC-2hf7A: 36.8	1rmtC-2hf7A: 99.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RMT_D_ADND1504_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	8 / 8	ASP A 46 PHE A 56 TYR A 70 LEU A 71 TRP A 77 ASP A 145 THR A 192 TYR A 193	AF3 A 800 ( 3.7A) None None None None None None None	0.44A	1rmtD-2hf7A: 36.7	1rmtD-2hf7A: 99.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B25_A_SAMA601_0 (HYPOTHETICAL PROTEIN)	4jvs	RAS-RELATED PROTEIN RAB-1A (Homo sapiens)	5 / 12	THR B 43 GLY B 23 GLY B 21 GLY B 69 ASP B 127	MG B 402 (-2.8A) GDP B 400 (-3.0A) GDP B 400 ( 3.5A) AF3 B 401 (-3.7A) GDP B 400 (-2.8A)	1.02A	2b25A-4jvsB: undetectable	2b25A-4jvsB: 20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B25_A_SAMA601_0 (HYPOTHETICAL PROTEIN)	4m8n	RAS-RELATED PROTEIN RAP-1B (Homo sapiens)	5 / 12	THR E 35 GLY E 15 GLY E 13 GLY E 60 ASP E 119	MG E 200 (-2.7A) GDP E 201 (-3.6A) GDP E 201 ( 3.1A) AF3 E 202 (-3.3A) GDP E 201 (-2.8A)	1.03A	2b25A-4m8nE: undetectable	2b25A-4m8nE: 20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B82_A_ADNA1001_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	10 / 10	PHE A 56 LYS A 60 GLU A 68 TYR A 70 LEU A 71 TRP A 77 GLY A 113 ASP A 145 THR A 192 TYR A 193	None None None None None None AF3 A 800 (-3.5A) None None None	0.66A	2b82A-2hf7A: 36.6	2b82A-2hf7A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B82_B_ADNB1002_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	9 / 9	PHE A 56 LYS A 60 GLU A 68 TYR A 70 LEU A 71 TRP A 77 GLY A 113 THR A 192 TYR A 193	None None None None None None AF3 A 800 (-3.5A) None None	0.56A	2b82B-2hf7A: 37.1	2b82B-2hf7A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B8J_A_SPMA653_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	9 / 9	ASP A 46 PHE A 56 TRP A 57 LYS A 60 TYR A 70 GLY A 113 ASP A 145 THR A 192 TYR A 193	AF3 A 800 ( 3.7A) None None None None AF3 A 800 (-3.5A) None None None	0.46A	2b8jA-2hf7A: 37.0	2b8jA-2hf7A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2B8J_B_ADNB331_1 (CLASS B ACID PHOSPHATASE)	2hf7	CLASS B ACID PHOSPHATASE (Escherichia coli)	10 / 10	ASP A 46 SER A 53 PHE A 56 TYR A 70 LEU A 71 TRP A 77 GLY A 113 ARG A 114 THR A 192 TYR A 193	AF3 A 800 ( 3.7A) None None None None None AF3 A 800 (-3.5A) None None None	0.23A	2b8jB-2hf7A: 34.4	2b8jB-2hf7A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BEX_F_PAUF248_0 (TYPE III PANTOTHENATE KINASE)	4m8n	PLEXINC1 INTRACELLULAR REGION RAS-RELATED PROTEIN RAP-1B (Danio rerio; Homo sapiens)	5 / 11	LYS E 16 THR E 35 ASN E 116 GLY E 12 ARG A 711	AF3 E 202 ( 3.1A) MG E 200 (-2.7A) GDP E 201 (-3.2A) AF3 E 202 (-3.5A) GDP E 201 ( 2.9A)	1.40A	3bexE-4m8nE: undetectable 3bexF-4m8nE: undetectable	3bexE-4m8nE: 21.59 3bexF-4m8nE: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_G_TFPG201_1 (PROTEIN S100-A4)	4jvs	PUTATIVE UNCHARACTERIZED PROTEIN RAS-RELATED PROTEIN RAB-1A (Homo sapiens; Legionella drancourtii)	5 / 9	GLY B 69 GLY B 23 ILE B 41 MET A 445 PHE A 448	AF3 B 401 (-3.7A) GDP B 400 (-3.0A) None None None	1.40A	3ko0F-4jvsB: undetectable 3ko0G-4jvsB: undetectable	3ko0F-4jvsB: 20.99 3ko0G-4jvsB: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_R_TFPR201_1 (PROTEIN S100-A4)	4jvs	PUTATIVE UNCHARACTERIZED PROTEIN RAS-RELATED PROTEIN RAB-1A (Homo sapiens; Legionella drancourtii)	5 / 10	GLY B 23 ILE B 41 MET A 445 PHE A 448 GLY B 69	GDP B 400 (-3.0A) None None None AF3 B 401 (-3.7A)	1.34A	3ko0R-4jvsB: undetectable 3ko0T-4jvsB: undetectable	3ko0R-4jvsB: 20.99 3ko0T-4jvsB: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXJ_A_SAMA258_0 (PUTATIVE METHYLTRANSFERASE)	5c2k	TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1 (Homo sapiens)	5 / 12	ARG A 247 GLN A 63 GLY A 12 GLY A 62 ASN A 94	GDP A 503 ( 3.5A) AF3 A 502 (-3.2A) None AF3 A 502 (-3.4A) None	1.21A	3sxjA-5c2kA: undetectable	3sxjA-5c2kA: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXJ_B_SAMB258_0 (PUTATIVE METHYLTRANSFERASE)	5c2k	TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1 (Homo sapiens)	5 / 12	ARG A 247 GLN A 63 GLY A 12 GLY A 62 ASN A 94	GDP A 503 ( 3.5A) AF3 A 502 (-3.2A) None AF3 A 502 (-3.4A) None	1.22A	3sxjB-5c2kA: undetectable	3sxjB-5c2kA: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T7S_B_SAMB300_0 (PUTATIVE METHYLTRANSFERASE)	5c2k	TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1 (Homo sapiens)	5 / 12	ARG A 247 GLN A 63 GLY A 12 GLY A 62 ASN A 94	GDP A 503 ( 3.5A) AF3 A 502 (-3.2A) None AF3 A 502 (-3.4A) None	1.23A	3t7sB-5c2kA: undetectable	3t7sB-5c2kA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T7S_D_SAMD300_0 (PUTATIVE METHYLTRANSFERASE)	5c2k	TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1 (Homo sapiens)	5 / 12	ARG A 247 GLN A 63 GLY A 12 GLY A 62 ASN A 94	GDP A 503 ( 3.5A) AF3 A 502 (-3.2A) None AF3 A 502 (-3.4A) None	1.21A	3t7sD-5c2kA: undetectable	3t7sD-5c2kA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD2_1 (CYTOCHROME P450 2D6)	4xpz	RNA POLYMERASE II SUBUNIT A C-TERMINAL DOMAIN PHOSPHATASE (Schizosaccharomy ces pombe)	5 / 9	PHE A 264 LEU A 171 VAL A 253 LEU A 230 ILE A 257	None AF3 A 601 (-4.0A) None None None	1.04A	3tbgD-4xpzA: undetectable	3tbgD-4xpzA: 20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_H_ACTH503_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	2ynm	LIGHT-INDEPENDENT PROTOCHLOROPHYLLIDE REDUCTASE IRON-SULFUR ATP-BINDING PROTEIN (Prochlorococcus marinus)	4 / 7	ARG A 187 ALA A 184 ILE A 188 GLY A 154	None None None AF3 A1299 (-3.5A)	0.85A	3v4tH-2ynmA: undetectable	3v4tH-2ynmA: 23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A3U_A_ACTA1358_0 (NADH:FLAVIN OXIDOREDUCTASE/NADH OXIDASE)	4m8n	PLEXINC1 INTRACELLULAR REGION RAS-RELATED PROTEIN RAP-1B (Danio rerio; Homo sapiens)	5 / 9	PRO E 34 GLN E 63 ARG A 711 GLY E 12 VAL E 14	AF3 E 202 ( 4.3A) AF3 E 202 (-3.5A) GDP E 201 ( 2.9A) AF3 E 202 (-3.5A) GDP E 201 (-4.3A)	1.47A	4a3uA-4m8nE: undetectable	4a3uA-4m8nE: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A3U_B_ACTB1358_0 (NADH:FLAVIN OXIDOREDUCTASE/NADH OXIDASE)	4m8n	PLEXINC1 INTRACELLULAR REGION RAS-RELATED PROTEIN RAP-1B (Danio rerio; Homo sapiens)	5 / 7	PRO E 34 GLN E 63 ARG A 711 GLY E 12 VAL E 14	AF3 E 202 ( 4.3A) AF3 E 202 (-3.5A) GDP E 201 ( 2.9A) AF3 E 202 (-3.5A) GDP E 201 (-4.3A)	1.48A	4a3uB-4m8nE: undetectable	4a3uB-4m8nE: 18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A3U_B_ACTB1358_0 (NADH:FLAVIN OXIDOREDUCTASE/NADH OXIDASE)	5c2k	TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1 (Homo sapiens)	4 / 7	PRO A 36 GLN A 63 ARG A 247 GLY A 14	AF3 A 502 (-4.5A) AF3 A 502 (-3.2A) GDP A 503 ( 3.5A) AF3 A 502 (-3.3A)	0.90A	4a3uB-5c2kA: undetectable	4a3uB-5c2kA: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EHG_C_SAMC4001_0 (RNA-DIRECTED RNA POLYMERASE NS5)	4m8n	PLEXINC1 INTRACELLULAR REGION RAS-RELATED PROTEIN RAP-1B (Danio rerio; Homo sapiens)	5 / 12	GLY E 15 GLY E 60 GLY E 13 VAL A1004 ILE E 36	GDP E 201 (-3.6A) AF3 E 202 (-3.3A) GDP E 201 ( 3.1A) None None	0.97A	5ehgC-4m8nE: undetectable	5ehgC-4m8nE: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	4xpz	RNA POLYMERASE II SUBUNIT A C-TERMINAL DOMAIN PHOSPHATASE (Schizosaccharomy ces pombe)	4 / 5	VAL A 253 HIS A 177 LEU A 226 ASP A 172	None None None AF3 A 601 ( 4.0A)	1.42A	5vcvA-4xpzA: undetectable	5vcvA-4xpzA: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_B_SAMB301_0 (METHYLTRANSFERASE)	4m8n	PLEXINC1 INTRACELLULAR REGION RAS-RELATED PROTEIN RAP-1B (Danio rerio; Homo sapiens)	5 / 12	GLY E 15 GLY E 60 GLY E 13 VAL A1004 ILE E 36	GDP E 201 (-3.6A) AF3 E 202 (-3.3A) GDP E 201 ( 3.1A) None None	0.95A	5vimB-4m8nE: undetectable	5vimB-4m8nE: 20.14

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1KB9_A_PCFA514_0","CYTOCHROME B;CYTOCHROME C1, HEME PROTEIN;UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN I;UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT","4jvs","PUTATIVE UNCHARACTERIZED PROTEIN;RAS-RELATED PROTEIN RAB-1A","Legionella drancourtii;Homo sapiens",4,"ILE B  76;VAL A 438;MET A 445;SER B  42","None;None;None;AF3 B 401 (-2.0A)","1.10A","1kb9A-4jvsB:undetectable;1kb9C-4jvsB:undetectable;1kb9D-4jvsB:undetectable;1kb9E-4jvsB:undetectable",null],["1RMT_A_ADNA1501_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",10,"ASP A  46;PHE A  56;TYR A  70;LEU A  71;TRP A  77;THR A 112;GLY A 113;ARG A 114;THR A 192;TYR A 193","AF3 A 800 ( 3.7A);None;None;None;None;AF3 A 800 (-3.6A);AF3 A 800 (-3.5A);None;None;None","0.31A","1rmtA-2hf7A:33.9","1kb9A-4jvsB:18.41;1kb9C-4jvsB:17.16;1kb9D-4jvsB:19.92;1kb9E-4jvsB:20.20"],["1RMT_C_ADNC1503_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",8,"ASP A  46;PHE A  56;TYR A  70;LEU A  71;TRP A  77;GLY A 113;ASP A 145;TYR A 193","AF3 A 800 ( 3.7A);None;None;None;None;AF3 A 800 (-3.5A);None;None","0.26A","1rmtC-2hf7A:36.8","1rmtA-2hf7A:99.53"],["1RMT_D_ADND1504_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",8,"ASP A  46;PHE A  56;TYR A  70;LEU A  71;TRP A  77;ASP A 145;THR A 192;TYR A 193","AF3 A 800 ( 3.7A);None;None;None;None;None;None;None","0.44A","1rmtD-2hf7A:36.7","1rmtC-2hf7A:99.53"],["2B25_A_SAMA601_0","HYPOTHETICAL PROTEIN","4jvs","RAS-RELATED PROTEIN RAB-1A","Homo sapiens",5,"THR B  43;GLY B  23;GLY B  21;GLY B  69;ASP B 127"," MG B 402 (-2.8A);GDP B 400 (-3.0A);GDP B 400 ( 3.5A);AF3 B 401 (-3.7A);GDP B 400 (-2.8A)","1.02A","2b25A-4jvsB:undetectable","1rmtD-2hf7A:99.53"],["2B25_A_SAMA601_0","HYPOTHETICAL PROTEIN","4m8n","RAS-RELATED PROTEIN RAP-1B","Homo sapiens",5,"THR E  35;GLY E  15;GLY E  13;GLY E  60;ASP E 119"," MG E 200 (-2.7A);GDP E 201 (-3.6A);GDP E 201 ( 3.1A);AF3 E 202 (-3.3A);GDP E 201 (-2.8A)","1.03A","2b25A-4m8nE:undetectable","2b25A-4jvsB:20.59"],["2B82_A_ADNA1001_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",10,"PHE A  56;LYS A  60;GLU A  68;TYR A  70;LEU A  71;TRP A  77;GLY A 113;ASP A 145;THR A 192;TYR A 193","None;None;None;None;None;None;AF3 A 800 (-3.5A);None;None;None","0.66A","2b82A-2hf7A:36.6","2b25A-4m8nE:20.00"],["2B82_B_ADNB1002_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",9,"PHE A  56;LYS A  60;GLU A  68;TYR A  70;LEU A  71;TRP A  77;GLY A 113;THR A 192;TYR A 193","None;None;None;None;None;None;AF3 A 800 (-3.5A);None;None","0.56A","2b82B-2hf7A:37.1","2b82A-2hf7A:100.00"],["2B8J_A_SPMA653_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",9,"ASP A  46;PHE A  56;TRP A  57;LYS A  60;TYR A  70;GLY A 113;ASP A 145;THR A 192;TYR A 193","AF3 A 800 ( 3.7A);None;None;None;None;AF3 A 800 (-3.5A);None;None;None","0.46A","2b8jA-2hf7A:37.0","2b82B-2hf7A:100.00"],["2B8J_B_ADNB331_1","CLASS B ACID PHOSPHATASE","2hf7","CLASS B ACID PHOSPHATASE","Escherichia coli",10,"ASP A  46;SER A  53;PHE A  56;TYR A  70;LEU A  71;TRP A  77;GLY A 113;ARG A 114;THR A 192;TYR A 193","AF3 A 800 ( 3.7A);None;None;None;None;None;AF3 A 800 (-3.5A);None;None;None","0.23A","2b8jB-2hf7A:34.4","2b8jA-2hf7A:100.00"],["3BEX_F_PAUF248_0","TYPE III PANTOTHENATE KINASE","4m8n","PLEXINC1 INTRACELLULAR REGION;RAS-RELATED PROTEIN RAP-1B","Danio rerio;Homo sapiens",5,"LYS E  16;THR E  35;ASN E 116;GLY E  12;ARG A 711","AF3 E 202 ( 3.1A); MG E 200 (-2.7A);GDP E 201 (-3.2A);AF3 E 202 (-3.5A);GDP E 201 ( 2.9A)","1.40A","3bexE-4m8nE:undetectable;3bexF-4m8nE:undetectable","2b8jB-2hf7A:100.00"],["3KO0_G_TFPG201_1","PROTEIN S100-A4;PROTEIN S100-A4","4jvs","PUTATIVE UNCHARACTERIZED PROTEIN;RAS-RELATED PROTEIN RAB-1A","Homo sapiens;Legionella drancourtii",5,"GLY B  69;GLY B  23;ILE B  41;MET A 445;PHE A 448","AF3 B 401 (-3.7A);GDP B 400 (-3.0A);None;None;None","1.40A","3ko0F-4jvsB:undetectable;3ko0G-4jvsB:undetectable","3bexE-4m8nE:21.59;3bexF-4m8nE:21.59"],["3KO0_R_TFPR201_1","PROTEIN S100-A4;PROTEIN S100-A4","4jvs","PUTATIVE UNCHARACTERIZED PROTEIN;RAS-RELATED PROTEIN RAB-1A","Homo sapiens;Legionella drancourtii",5,"GLY B  23;ILE B  41;MET A 445;PHE A 448;GLY B  69","GDP B 400 (-3.0A);None;None;None;AF3 B 401 (-3.7A)","1.34A","3ko0R-4jvsB:undetectable;3ko0T-4jvsB:undetectable","3ko0F-4jvsB:20.99;3ko0G-4jvsB:20.99"],["3SXJ_A_SAMA258_0","PUTATIVE METHYLTRANSFERASE","5c2k","TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1","Homo sapiens",5,"ARG A 247;GLN A  63;GLY A  12;GLY A  62;ASN A  94","GDP A 503 ( 3.5A);AF3 A 502 (-3.2A);None;AF3 A 502 (-3.4A);None","1.21A","3sxjA-5c2kA:undetectable","3ko0R-4jvsB:20.99;3ko0T-4jvsB:20.99"],["3SXJ_B_SAMB258_0","PUTATIVE METHYLTRANSFERASE","5c2k","TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1","Homo sapiens",5,"ARG A 247;GLN A  63;GLY A  12;GLY A  62;ASN A  94","GDP A 503 ( 3.5A);AF3 A 502 (-3.2A);None;AF3 A 502 (-3.4A);None","1.22A","3sxjB-5c2kA:undetectable","3sxjA-5c2kA:21.14"],["3T7S_B_SAMB300_0","PUTATIVE METHYLTRANSFERASE","5c2k","TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1","Homo sapiens",5,"ARG A 247;GLN A  63;GLY A  12;GLY A  62;ASN A  94","GDP A 503 ( 3.5A);AF3 A 502 (-3.2A);None;AF3 A 502 (-3.4A);None","1.23A","3t7sB-5c2kA:undetectable","3sxjB-5c2kA:21.14"],["3T7S_D_SAMD300_0","PUTATIVE METHYLTRANSFERASE","5c2k","TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1","Homo sapiens",5,"ARG A 247;GLN A  63;GLY A  12;GLY A  62;ASN A  94","GDP A 503 ( 3.5A);AF3 A 502 (-3.2A);None;AF3 A 502 (-3.4A);None","1.21A","3t7sD-5c2kA:undetectable","3t7sB-5c2kA:20.66"],["3TBG_D_RTZD2_1","CYTOCHROME P450 2D6","4xpz","RNA POLYMERASE II SUBUNIT A C-TERMINAL DOMAIN PHOSPHATASE","Schizosaccharomyces pombe",5,"PHE A 264;LEU A 171;VAL A 253;LEU A 230;ILE A 257","None;AF3 A 601 (-4.0A);None;None;None","1.04A","3tbgD-4xpzA:undetectable","3t7sD-5c2kA:20.66"],["3V4T_H_ACTH503_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","2ynm","LIGHT-INDEPENDENT PROTOCHLOROPHYLLIDE REDUCTASE IRON-SULFUR ATP-BINDING PROTEIN","Prochlorococcus marinus",4,"ARG A 187;ALA A 184;ILE A 188;GLY A 154","None;None;None;AF3 A1299 (-3.5A)","0.85A","3v4tH-2ynmA:undetectable","3tbgD-4xpzA:20.84"],["4A3U_A_ACTA1358_0","NADH:FLAVIN OXIDOREDUCTASE\/NADH OXIDASE","4m8n","PLEXINC1 INTRACELLULAR REGION;RAS-RELATED PROTEIN RAP-1B","Danio rerio;Homo sapiens",5,"PRO E  34;GLN E  63;ARG A 711;GLY E  12;VAL E  14","AF3 E 202 ( 4.3A);AF3 E 202 (-3.5A);GDP E 201 ( 2.9A);AF3 E 202 (-3.5A);GDP E 201 (-4.3A)","1.47A","4a3uA-4m8nE:undetectable","3v4tH-2ynmA:23.04"],["4A3U_B_ACTB1358_0","NADH:FLAVIN OXIDOREDUCTASE\/NADH OXIDASE","4m8n","PLEXINC1 INTRACELLULAR REGION;RAS-RELATED PROTEIN RAP-1B","Danio rerio;Homo sapiens",5,"PRO E  34;GLN E  63;ARG A 711;GLY E  12;VAL E  14","AF3 E 202 ( 4.3A);AF3 E 202 (-3.5A);GDP E 201 ( 2.9A);AF3 E 202 (-3.5A);GDP E 201 (-4.3A)","1.48A","4a3uB-4m8nE:undetectable","4a3uA-4m8nE:18.85"],["4A3U_B_ACTB1358_0","NADH:FLAVIN OXIDOREDUCTASE\/NADH OXIDASE","5c2k","TRANSFORMING PROTEIN RHOA,RAC GTPASE-ACTIVATING PROTEIN 1","Homo sapiens",4,"PRO A  36;GLN A  63;ARG A 247;GLY A  14","AF3 A 502 (-4.5A);AF3 A 502 (-3.2A);GDP A 503 ( 3.5A);AF3 A 502 (-3.3A)","0.90A","4a3uB-5c2kA:undetectable","4a3uB-4m8nE:18.85"],["5EHG_C_SAMC4001_0","RNA-DIRECTED RNA POLYMERASE NS5","4m8n","PLEXINC1 INTRACELLULAR REGION;RAS-RELATED PROTEIN RAP-1B","Danio rerio;Homo sapiens",5,"GLY E  15;GLY E  60;GLY E  13;VAL A1004;ILE E  36","GDP E 201 (-3.6A);AF3 E 202 (-3.3A);GDP E 201 ( 3.1A);None;None","0.97A","5ehgC-4m8nE:undetectable","4a3uB-5c2kA:21.43"],["5VCV_A_1N1A404_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","4xpz","RNA POLYMERASE II SUBUNIT A C-TERMINAL DOMAIN PHOSPHATASE","Schizosaccharomyces pombe",4,"VAL A 253;HIS A 177;LEU A 226;ASP A 172","None;None;None;AF3 A 601 ( 4.0A)","1.42A","5vcvA-4xpzA:undetectable","5ehgC-4m8nE:19.41"],["5VIM_B_SAMB301_0","METHYLTRANSFERASE","4m8n","PLEXINC1 INTRACELLULAR REGION;RAS-RELATED PROTEIN RAP-1B","Danio rerio;Homo sapiens",5,"GLY E  15;GLY E  60;GLY E  13;VAL A1004;ILE E  36","GDP E 201 (-3.6A);AF3 E 202 (-3.3A);GDP E 201 ( 3.1A);None;None","0.95A","5vimB-4m8nE:undetectable","5vcvA-4xpzA:22.78"]]